Pfizer, A Worldwide Producer Of Case Study

As was mentioned, four meatpackers have a monopoly control over the market. If they don't want premium beef, it won't matter what the ranchers do. The program could yield many benefits for Pfizer, and the beef market as a whole, but perhaps the first communications on the program should be with the meatpackers. Recommended Solution

Cost pressures in the beef industry are threatening Pfizer's ability to sell premium medicinal products to the cattle market. Sales of these premium pharmaceuticals allow Pfizer to aggressively offer new and innovative products and to support the ranching industry through trade events and technical support. Pfizer needs to preserve its...


A quality beef brand, which would necessitate a standard of medical care for the cattle, would help Pfizer maintain its pricing and cash in on the superior quality of its products. As such, working with industry partners to develop this brand is the best course of action if Pfizer hopes to protect sales and pricing.
Works Cited

Cravens, David W. And Piercy, Nigel F. (2003). Strategic Marketing. McGraw-Hill Irwin, Boston.

Sources Used in Documents:

Works Cited

Cravens, David W. And Piercy, Nigel F. (2003). Strategic Marketing. McGraw-Hill Irwin, Boston.

Cite this Document:

"Pfizer A Worldwide Producer Of" (2006, October 03) Retrieved June 24, 2024, from

"Pfizer A Worldwide Producer Of" 03 October 2006. Web.24 June. 2024. <>

"Pfizer A Worldwide Producer Of", 03 October 2006, Accessed.24 June. 2024,

Related Documents
Market Driven Management
PAGES 75 WORDS 25695

Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense

Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this

Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit

Managing All Stakeholders in the Context of a Merger Process Review of the Relevant Literature Types of Mergers Identifying All Stakeholders in a Given Business Strategic Market Factors Driving Merger Activity Selection Process for Merger Candidates Summary, Conclusion, and Recommendations The Challenge of Managing All Stakeholders in the Context of a Merger Process Mergers and acquisitions became central features of organizational life in the last part of the 20th century, particularly as organizations seek to establish and

Procter and Gamble P &

There is also an inability to distinguish the product lines from that of the competitors, although the company has succeeded effectively in creating brand recognition for their products. Customer loyalty and brand loyalty of the past cannot always be counted upon to create the necessary profitability for the company. This is obvious in the case of P & G. that the marketing strategy that the organization uses for different products